enGene Therapeutics (ENGN) Change in Accured Expenses (2023 - 2026)
enGene Therapeutics (ENGN) reported Change in Accured Expenses of $5.04 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$1.06 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, enGene Therapeutics' Change in Accured Expenses came in at $11.1 million; for FY2025 (ended Oct 31, 2025), it came in at $3.13 million, down 40.1% from FY2024.
- Change in Accured Expenses has a three-year compound annual growth rate of 10.2% (FY2022 to FY2025).
- By fiscal year, Change in Accured Expenses came in at $5.23 million in FY2024 (+502.0%), $868,000 in FY2023 (-62.9%) and $2.34 million in FY2022.
- The fiscal Q3 2026 figure ranks as the highest quarterly Change in Accured Expenses in data going back to fiscal Q1 2023.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$2.49 million (Q2 2026), $4.39 million (Q1 2026) and $4.15 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | enGene Therapeutics | 130.01 Mn | 130.01 Mn | - | 5.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 5.04 Mn |
| Apr 30, 2026 | -2.49 Mn |
| Jan 31, 2026 | 4.39 Mn |
| Oct 31, 2025 | 4.15 Mn |
| Jul 31, 2025 | -1.06 Mn |
| Apr 30, 2025 | 3.92 Mn |
| Jan 31, 2025 | -3.88 Mn |
| Oct 31, 2024 | -540,000.00 |
| Jul 31, 2024 | 3.20 Mn |
| Apr 30, 2024 | 414,000.00 |
| Jan 31, 2024 | 2.15 Mn |
| Oct 31, 2023 | 2.97 Mn |
| Jul 31, 2023 | 172,000.00 |
| Apr 30, 2023 | -450,000.00 |
| Jan 31, 2023 | -1.82 Mn |
API Access
enGene Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();